Doctor Vera Gielen
Novartis Pharmaceuticals UK Limited, Frimley (United Kingdom of Great Britain & Northern Ireland)
Better health-related quality of life in patients treated with sacubitril/valsartan compared with enalapril, irrespective of NYHA class: Analysis of EQ-5D in PARADIGM-HF
Event: ESC Congress 2017
Topic: Pharmacologic therapy
Session: Chronic heart failure (CHF)
ESC 365 is supported by
